Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure.

Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Muñoz R, Reus V, Hall SM.

Nicotine Tob Res. 2005 Jun;7(3):453-60.

PMID:
16085513
2.

Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.

McClernon FJ, Kollins SH, Lutz AM, Fitzgerald DP, Murray DW, Redman C, Rose JE.

Psychopharmacology (Berl). 2008 Mar;197(1):95-105. Epub 2007 Nov 25.

PMID:
18038223
3.

Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.

Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH.

Nicotine Tob Res. 2001 Nov;3(4):353-9.

PMID:
11694203
4.

Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology.

Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF.

Addict Behav. 2003 Aug;28(6):1149-57.

PMID:
12834657
5.

The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination.

Gehricke JG, Whalen CK, Jamner LD, Wigal TL, Steinhoff K.

Nicotine Tob Res. 2006 Feb;8(1):37-47.

PMID:
16497598
6.

Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder.

Gehricke JG, Hong N, Whalen CK, Steinhoff K, Wigal TL.

Psychol Addict Behav. 2009 Dec;23(4):644-55. doi: 10.1037/a0017441.

PMID:
20025370
7.

Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.

Kollins SH, McClernon FJ, Fuemmeler BF.

Arch Gen Psychiatry. 2005 Oct;62(10):1142-7.

PMID:
16203959
8.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
9.

Personality differences related to smoking and adult attention deficit hyperactivity disorder.

Downey KK, Pomerleau CS, Pomerleau OF.

J Subst Abuse. 1996;8(1):129-35.

PMID:
8743773
10.

Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.

Covey LS, Manubay J, Jiang H, Nortick M, Palumbo D.

Nicotine Tob Res. 2008 Dec;10(12):1717-25. doi: 10.1080/14622200802443536.

11.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
12.

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M.

J Neural Transm Suppl. 2007;(72):311-5.

PMID:
17982908
14.

Nicotine effects on adults with attention-deficit/hyperactivity disorder.

Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, Rose JE, March J.

Psychopharmacology (Berl). 1996 Jan;123(1):55-63.

PMID:
8741955
15.

Does a childhood history of externalizing problems predict smoking during pregnancy?

Kodl MM, Wakschlag LS.

Addict Behav. 2004 Feb;29(2):273-9.

PMID:
14732416
16.

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.

Cheng JY, Chen RY, Ko JS, Ng EM.

Psychopharmacology (Berl). 2007 Oct;194(2):197-209. Epub 2007 Jun 16.

PMID:
17572882
17.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
18.

Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.

Cohen-Yavin I, Yoran-Hegesh R, Strous RD, Kotler M, Weizman A, Spivak B.

Clin Neuropharmacol. 2009 Jul-Aug;32(4):179-82. doi: 10.1097/WNF.0b013e318183796d.

PMID:
19644227
19.

Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study.

Bakken RJ, Paczkowski M, Kramer HP, Axelson AA, Williams DW, Malcolm SK, Sumner CR, Kelsey DK.

Curr Med Res Opin. 2008 Feb;24(2):449-60. doi: 10.1185/030079908X253627 .

PMID:
18179733
20.

The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.

Biederman J, Petty CR, Dolan C, Hughes S, Mick E, Monuteaux MC, Faraone SV.

Psychol Med. 2008 Jul;38(7):1027-36. doi: 10.1017/S0033291707002668. Epub 2008 Jan 21.

PMID:
18205967
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk